Psyence Group Inc. (CSE:PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.1700
+0.0100 (6.25%)
Jun 27, 2025, 9:30 AM EDT
-24.44%
Market Cap 1.31M
Revenue (ttm) n/a
Net Income (ttm) -65.83M
Shares Out 9.39M
EPS (ttm) -7.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,941
Average Volume 614
Open 0.1700
Previous Close 0.1600
Day's Range 0.1700 - 0.1700
52-Week Range 0.1050 - 0.5250
Beta 1.21
RSI 67.39
Earnings Date Jul 30, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.